FDA Inspection
Siegfried (St. Vulbas) SASSiegfried (St. Vulbas) SAS – FDA Inspection, Jan 13, 2023
Record Details
This FDA Inspection record concerns Siegfried (St. Vulbas) SAS, with an inspection on January 13, 2023, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Siegfried (St. Vulbas) SAS
- Inspection Date
- January 13, 2023
- Product Type
- Drugs
View Company Profile
ID · 25121383-0606-4877-903d-a0d564e04013
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1247255
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Siegfried (St. Vulbas) SAS
5| Date | Classification | Office | Project area |
|---|---|---|---|
| November 7, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 29, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 23, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 18, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 22, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Siegfried (St. Vulbas) SAS
- FDA Inspection 1125537 - 2019-11-07
- FDA Inspection 1063219 - 2018-06-29
- FDA Inspection 990166 - 2016-09-23
- FDA Inspection 889637 - 2013-12-18
- FDA Inspection 645432 - 2010-01-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.